mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.8 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |